Role of β-lactamase inhibitors on cefiderocol activity against carbapenem-resistant Acinetobacter species

Int J Antimicrob Agents. 2023 Jan;61(1):106700. doi: 10.1016/j.ijantimicag.2022.106700. Epub 2022 Dec 5.
No abstract available

Keywords: Acinetobacter; NDM-1; PER; carbapenem-resistance; cefiderocol; diazabicyclooctanes (DBOs); sulbactam.

Publication types

  • Letter

MeSH terms

  • Acinetobacter baumannii*
  • Acinetobacter*
  • Anti-Bacterial Agents / pharmacology
  • Carbapenems / pharmacology
  • Cefiderocol
  • Cephalosporins / pharmacology
  • Microbial Sensitivity Tests
  • beta-Lactamase Inhibitors / pharmacology
  • beta-Lactamases / genetics

Substances

  • beta-Lactamase Inhibitors
  • Cephalosporins
  • Anti-Bacterial Agents
  • Carbapenems
  • beta-Lactamases